| CTRI Number |
CTRI/2024/01/062065 [Registered on: 30/01/2024] Trial Registered Prospectively |
| Last Modified On: |
05/01/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device |
| Study Design |
Other |
|
Public Title of Study
|
To evaluate the performance of near infrared-based device in the management of traumatic brain injury patients. |
|
Scientific Title of Study
|
Feasibility Assessment of CEREBOⓇ in conjunction with CEREBOⓇ Research Unit (CCRU)to detect structural and functional injury among brain injury patients |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| IEC/RMC/2023/1061; Version/1;30/11/23 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vijaya Sekhar M V |
| Designation |
Head of Department |
| Affiliation |
Government General Hospital |
| Address |
Department of Neurosurgery
Division - Neurosurgery
First Floor
Kakinada
East Godavari ANDHRA PRADESH 533003 India |
| Phone |
9849115723 |
| Fax |
|
| Email |
nsvijayasekhar@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vijaya Sekhar M V |
| Designation |
Head of Department |
| Affiliation |
Government General Hospital |
| Address |
Department of Neurosurgery
Division - Neurosurgery
First Floor
Kakinada
East Godavari ANDHRA PRADESH 533003 India |
| Phone |
9849115723 |
| Fax |
|
| Email |
nsvijayasekhar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Vijaya Sekhar M V |
| Designation |
Head of Department |
| Affiliation |
Government General Hospital |
| Address |
Department of Neurosurgery
Division - Neurosurgery
First Floor
Kakinada
East Godavari ANDHRA PRADESH 533003 India |
| Phone |
9849115723 |
| Fax |
|
| Email |
nsvijayasekhar@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dr Vijaya Sekhar M V |
| Address |
Government General Hospital
Kakinada
Andhra Pradesh
533003
India |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vijaya Sekhar |
Rangaraya Medical College, Government General Hospital |
Department of Neurosurgery,
Division - Neurosurgery,
First Floor
Kakinada East Godavari ANDHRA PRADESH |
9849115723
nsvijayasekhar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Rangaraya Medical College Institutional Ethics Committee Cell |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: S068||Other specified intracranial injuries, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Near infrared based Device |
Participants will be randomly allocated to the experimental and the control group. The experimental group would receive an additional scan using the CCRU device before proceeding to their standard care pathway. The results from the CCRU device would then be compared with the results of the standard CT or MRI scans to evaluate the effectiveness and accuracy of CCRU in detecting traumatic intracranial injuries. Outcomes such as sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio, as well as other relevant clinical outcomes (like time to diagnosis, impact on treatment decisions, etc.), would be collected and analyzed.
|
| Comparator Agent |
Participants under going the usual standard of care |
The control group would undergo the usual care pathway for suspected traumatic brain injury, which typically includes a clinical evaluation and a head CT or MRI scan as determined by the treating physicians judgment and existing clinical guidelines. Patients in the control group would not receive the CCRU scan. Their treatment and diagnosis would not be influenced by the data or results provided by the experimental device. The outcomes of the control group provide the baseline against which the experimental groups results are compared. |
|
|
Inclusion Criteria
|
| Age From |
0.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1. Traumatic and non-traumatic patients who are referred for a head CT or an MRI scan.
2. Suspected CVA or infarct
|
|
| ExclusionCriteria |
| Details |
1. History of neurosurgical procedure (e.g. decompressive craniectomy) with residual bone flap.
2. Post-Operative patients.
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To assess the structural and functional injury in traumatic brain injury patients |
3 years |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduction in the mean transfer time from injury to first head CT Scan |
3 years |
|
|
Target Sample Size
|
Total Sample Size="180" Sample Size from India="180"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
01/02/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This clinical study employs a quasi-experimental design with a randomized controlled trial to assess the efficacy of CEREBO® in conjunction with the CEREBO® Research Unit for traumatic brain injury management. The study will evaluate the clinical performance of the device in assessing structural and functional injuries in traumatic brain injury patients. Additionally, it will compare the reduction in transfer time to the first head CT scan between the experimental and control groups. The study also focuses on assessing the impact of early detection of brain injuries, thereby aiding in the development of tailored rehabilitation strategies. |